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Abstract.  We have deleted cDNA sequences encoding 
portions of the carboxy-terminal end of a human type 
I epidermal keratin K14, and examined the molecular 
consequences of forcing the expression of these mu- 
tants in simple epithelial and squamous cell carcinoma 
lines. To follow the expression of our mutant products 
in transfected cells, we have tagged the 3' end of the 
K14 coding sequence with a  sequence encoding an an- 
tigenic domain of the neuropeptide substance P.  Using 
DNA transfection and immunohistochemistry (with an 
antibody against substance P), we have identified a 
collection of mutants that have a  wide range of mor- 
phological effects on the endogenous keratin filament 
networks of transfected cells. Mutants that are missing 
most of the nonhelical carboxy-terminal domain of K14 
incorporate into the endogenous keratin filaments with- 
out any visible perturbations on the network. In con- 
trast, mutants that are missing as few as  10 of the 310 
amino acids of the central a-helical domain of the 
polypeptide cause gross alterations in the keratin net- 
work.  In some cases, the entire cytoskeletal network of 
keratins was disrupted, leaving no evidence of 8-nm 
filaments. These results reveal the existence of a dy- 
namic exchange between newly synthesized subunits 
and preexisting keratin filaments. 
I 
NTERMEDIATE filament (IF)  1 proteins are expressed in 
virtually all mammalian cells.  Based on their tissue- 
specific expression, they can be subdivided into five dis- 
tinct groups: vimentin (expressed in cells of mesenchymal 
origin), glial fibrillary acidic protein (gliai cells), desmin 
(muscle cells),  neurofilament proteins  (neural cells),  and 
keratins (epithelial cells) (for review, see Geisler and Weber, 
1982; Steinert et al.,  1985). The lamins form a sixth class 
of IFs, but unlike the others they are universally expressed 
(for review, see Franke, 1987). Both in vivo and in vitro, all 
IF proteins have the capacity to assemble into 8-10 nm fila- 
ments in the apparent absence of any auxiliary proteins or 
factors. Whereas the five classes of tissue-specific IFs form 
extensive fibrous networks in the cytoplasm, the lamins form 
a lattice of filaments on the inner side of the nuclear mem- 
brane. 
Of all the IF proteins, the keratins are by far the most com- 
plex and diverse group. There are >20 keratins (40-70 kD) 
that are differentially expressed in different epithelia and at 
various stages of differentiation  and development (Fuchs and 
Green, 1980; Moll et al., 1982; Wu et al., 1982; Tseng et ai., 
1982). As such, they seem to be tailored to suit the special- 
ized structural needs of each higher eukaryotic epithelial 
cell. Keratins can be subdivided into two distinct classes: 
Type I keratins are acidic (pKi  =  4.5-5.5) and small (mol 
wt 40-56.5K),  whereas type II keratins are basic (pKi  = 
6.5-7.5) and generally larger (mol wt 53-67K) (Fuchs et al., 
1. Abbreviation  used in this paper:  IF,  intermediate filament. 
1981; Schiller et al.,  1982; Kim et al.,  1983; Magin et al., 
1983; Sun et al., 1984). Type I and type H keratins are fre- 
quently expressed as specific pairs, and at any one time, an 
epithelial cell will typically express one to three pairs of ker- 
atins (Eichner et al.,  1984). 
Like all IF proteins, type I and type II keratins have a cen- 
trai 310 amino acid residue domain consisting of four seg- 
ments which are predicted to be largely a-helical (Hanukoglu 
and Fuchs, 1982; 1983; Crewther et al., 1983; Jorcano et ai., 
1984a,  b;  Steinert et al.,  1983; 1984). The classification 
of keratins according to type is based on these sequences. 
Within the type I or type II keratin family, the helical regions 
of different keratins share 50--99 % sequence identity; kera- 
tins of opposite type share only 25-35 % homology in these 
domains. Across type lines, much of the homology resides at 
the end of the fourth helical segment, where a highly con- 
served sequence T Y R R L L E G E is found in nearly all 
intermediate filament proteins. 
The basic subunit structure of all IFs seems to be a dimer 
which is formed through a coiled-coil interaction between 
the helical domains of two polypeptide chains. The core of 
the  coiled-coil  is  stabilized by  hydrophobic interactions, 
hence giving rise to a periodicity of hydrophobic residues in 
the sequence within this region (McLachlan, 1978). In addi- 
tion, a conservation and periodicity in positively and nega- 
tively charged residues can be seen,  indicating that elec- 
trostatic  interactions may also  play an  important role  in 
stabilizing  the  coiled-coil  structure  (Parry  et  ai.,  1977; 
McLachlan and Stewart, 1982). 
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IF subunits (e.g., vimentin) can form homopolymers (Stein- 
err et al.,  1981; Geisler and Weber,  1981; Geisler et al., 
1982),  no keratin by itself is competent to form filaments 
(Steinert et al., 1976; Lee and Baden, 1976). However, when 
almost any two random type I and type II epithelial keratins 
are isolated and recombined in vitro,  8-nm filaments can 
form readily even across species lines (Hatzfeld and Franke, 
1985). Since type I keratins are generally acidic, while type 
II keratins are more basic, it seems reasonable that the coiled- 
coil dimer of the keratin filament is composed of a type I and 
a type II keratin, held together via hydrophobic and ionic in- 
teractions. Some biochemical studies have supported this no- 
tion (Woods and Inglis,  1984; Parry et al.,  1985). However, 
because stable tetramers form readily in solution (Quinlan et 
al.,  1984;  Soellner et al.,  1985),  the  composition of the 
dimer has been difficult to determine. Thus, although the ra- 
tio of type I and type II keratins in the tetramer is 1:1, it has 
not yet been resolved unequivocally whether two coiled-coil 
homodimers or two coiled-coil heterodimers come together 
to form a stable tetrameric subunit. 
The two polypeptide chains of  the dimer are aligned in reg- 
ister, and in a parallel fashion, with the two amino termini 
at one end and the two carboxy termini at the other. The two 
dimers in the tetrarner seem to be arranged in an antiparallel 
manner, but whether they are in register or staggered is still 
a controversial issue (Parry et al., 1985; Geisler et al., 1985). 
Once formed, tetramers assemble into a hierarchy of higher 
ordered structures:  an undetermined number of protofila- 
ments (2-3 nm) assemble into protofibrils (4.5 nm), and four 
protofibrils intertwine to form the resulting 8-nm filament 
(Aebi et al., 1983; Steven et al., 1983; Ip et al.,  1985; Eich- 
ner et al., 1986). It is not known whether newly synthesized 
tetramers can freely exchange with tetramers in preexisting 
keratin filaments, or whether the filaments, once formed, are 
static. 
While it seems clear that the helical domains of keratins 
are involved in the formation of the coiled-coil, the role of 
the  nonhelical amino- and carboxy-terminal sequences  in 
filament assembly has not been elucidated. These nonhelical 
termini are hypervariable in size and can be subdivided into 
at least three sequence groups: (a) the type I and type II kera- 
tins of epidermal cells have end domains that are unusually 
abundant in glycine and serine rich sequences (Hanukoglu 
and Fuchs, 1982;  1983; Steinert et al.,  1983;  1984; Jorcano 
et al., 1984a; b); (b) wool and possibly hair keratins have ter- 
minal segments that contain a number of cysteine and proline 
residues,  with  very few glycines (Crewther et al.,  1983; 
Dowling et al., 1986); and (c) simple epithelial keratins have 
termini that are not rich in any of these amino acids (Glass 
et al., 1985; Singer et al., 1986; Magin et al., 1986; Romano 
et al., 1986; Bader et al., 1986). In addition, the carboxy ter- 
mini of simple epithelial keratins seem to be unusually short. 
If these end domains are involved in filament formation, then 
the differences in their sequences may influence the proper- 
ties of the resulting filaments, as well as interfilament inter- 
actions and associations with other proteins and organelles. 
To determine more precisely the role that the nonhelical 
and helical sequences play in filament assembly, and to ex- 
amine the dynamics of keratin filaments in vivo, we have 
constructed a  series of deletion mutations at the carboxy- 
terminal end of a cDNA encoding the complete human epi- 
dermal type I keratin K14. By inserting the mutant cDNAs 
3' to an SV-40 promoter and enhancer, we could drive their 
expression in transfected simple epithelial cells and in an 
epidermal cell line derived from a squamous cell carcinoma 
of the skin. Using immunoblot analyses, we have monitored 
the  expression of the  transfected products  in  these cells. 
Using  immunofluorescence microscopy, we have assessed 
the effects of deleting carboxy-terminal sequences of K14 on 
its ability to incorporate into the endogenous keratin filament 
networks of the transfected cell types. 
Materials and Methods 
Cell Culture 
PtK2 cells were maintained in a 3:1 mixture of DME and Ham's F12 medium 
supplemented with 10% FBS. SCC 13 cells were obtained from Dr. James 
Rheinwald (Dana Farber Cancer Center, Harvard Medical School, Boston, 
MA), and were cultivated as described previously (Wu  and Rheinwald, 
1981). 
Construction of  Plasmid pJKl4. P 
(a) Construction of  a Fragment  Containing the 3' Porffon of  the 104 Cod- 
ing Sequence Linked to Substance P. Clone pKB-2 (Hanukoghi and Fuchs, 
1982) was digested with Ava II restriction endonuclease, and the ends were 
filled in using DNA polymerase I (Klenow). A 570-bp fragment containing 
the 3' coding sequence of K14 eDNA was isolated and purified. This frag- 
ment was missing sequence coding for the last five carboxy amino acids of 
the KI4 protein (see Fig. 1). Using T4 DNA ligase, the fragment was linked 
5' to a  1.6-kb Hinc II fragment of plasmid pAHP.2 (Munro and Pelham, 
1984), which contained the sequence encoding the neuropeptide substance 
P, followed by a TGA translation stop codon and the 3' noncoding sequence 
of a Drosophila hsp70 gene (Fig.  1 B). The joining recreated the Hine II 
site, which is marked (H)  in Fig.  I  A.  This ligated fragment was then 
cleaved at a unique Sac I site within the K14 sequence (see Fig. 1 A), and 
the 3' subfragrnent (containing the 3' portion of the K14 eDNA, substance 
P, and the 3' noncoding segment of the Drosophila hspTO  gene) was purified 
for further use below. This fragment had a 5' Sac I end and a flush 3' end. 
(b) Construction of a Fragment Containing the J' Portion of the 104 
Coding Sequence. A 500-bp Ava I/Kpn I fragment containing the transcrip- 
tion initiation site of the K14 gene (OK-l) and part of exun I (Marchuk et 
al.,  1984) was ligated to a 990-bp Kpn I/Stu I fragment containing the re- 
maining coding portion and the 3' noncoding portion of  the KI4 eDNA (KB- 
2). The ends of the fragment were filled in with Klenow, and the eDNA was 
inserted into the Hint II site of  plasmid pSP64 (Giudice, G. J., and E. :Fuchs, 
unpublished results).  This hybrid plasmid was first cleaved at its unique Eco 
RI site, 3' from the eDNA, and the ends were filled in with Klenow. The plas- 
mid was then cleaved at the Sac I site within the eDNA. The fragment contain- 
ing the pSP64 vector linked 5' to the K14 eDNA (extending from the transcrip- 
tion initiation  site of the K14 gene and including the coding sequence of K14 
up to the unique Sac I site) was isolated and purified for further use. This 
fragment had a flush 5' end resulting from the residual Eco RI site in pSP64 
and a Sac I 3' end. 
Ligation of  (a) and Co) Followed  by Their  Insertion into Plasmid  pJ1. The 
fragments generated in (a) and (b) above were ligated to create a plasmid con- 
taming the complete KI4 coding sequence (minus five carboxy-terminal amino 
acid residues) coupled to a sequence encoding 15 amino acid residues encom- 
passing substance P. These sequences were excised from this plasmid using 
Hind HI (in the pSP multiple cloning region) and Sfi I (in the pAHP.2 se- 
quences 3' from the hsp70 polyadenylatiun  signal).  The fragment was then 
subcloned into the plasmid pJ1 (Land et al., 1986) at the Hind HI/Sma I sites 
to produce pJK14-P. The completed construct is shown in Fig.  1 A. 
Construction of Deletion Mutants 
pJK14.P  DNA was cleaved at the unique Sal I site located just 5' to the sub- 
stance P sequence (S; see Fig. 1 A). Bal 31 exonuclease was used to generate 
various length deletions in the cDNA sequence. These fragments were treated 
with mung bean exonuclease to create blunt-ended DNA. The fragments were 
then cut at the unique Kpn I site in the 5' end of the eDNA (see Fig. 1), and 
the Kpn I-blunt-ended fragments were gel purified on Seaplaque agarose 
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Figure 1. Genetic map of plasmid pJK14-  P. 
(A) The construction of the plasmid pJK14.P 
is described in Materials and Methods. The 
components of the plasmid are represented 
as follows: (Hatched bars) The SV-40 early 
promoter (and origin of replication) and en- 
hancer  sequences  that  were used  to drive 
the  expression  of the  constructed  cDNA. 
The transcription  initiation site is marked 
by the arrow.  (Black box) The 5' untrans- 
lated  leader  sequence of the K14  mRNA. 
Also in this region, upstream from the K14 
sequence, is the Hind III/Hinc II polylinker 
portion of plasmid pSP64 (Promega Biotec, 
Madison,  WI),  which  was  included  as  a 
consequence  of  subcloning.  (White  box) 
The human  keratin K14 cDNA.  This  seg- 
ment is missing the sequence encoding the five carboxy-terminal amino acid residues and the TGA stop codon. The Hinc II-Sfi I fragment 
of plasmid pAHE2 (Munro and Pelham,  1984)  includes the sequences encoding the carboxy-terminal domain of neuropeptide substance 
E  (heavily stippled box) followed by a TGA stop codon, and the 3' noncoding sequence and polyadenylation signal (PA) of the Drosophila 
hsp70 gene (lightly stippled box). (ori) The origin of replication for plasmid pBR322 is indicated as is the ampicillin-resistance gene con- 
tained in plasmid pJl. Important restriction endonuclease sites are marked. H3, Hind III; S, Sal I; H, Hinc II; R/, Eco RI. (B) The relevant 
nucleotide sequences of the coding strands for plasmids pKB-2 and pAHE2 are shown so that the reader can examine the junctions between 
the K14 and substance  P  sequences and the substance  P  and hsp70 sequences.  (Squiggled line)  The binding site of the primer used for 
DNA sequencing. 
(FMC Corporation, Philadelphia, PA). The fragments encoding various per- 
tions of the carboxy end of K14 were then ligated back into pJK14.P at the 
Kpn I/Sal I site (after filling in the Sal I site with Klenow fragment). Ligated 
DNA was transformed into bacterial strains MC1061 and DH1. 
DNA Sequencing 
To determine which Bal 31 deletion clones were in the proper reading frame 
for substance P expression, plasmid DNA from each deletion clone was iso- 
lated and  sequenced  using  the double-stranded  sequencing  protocol  de- 
scribed by Chen and Seeberg (1985). 
D NA Transfections 
DNA was transfected into PtK2 cells using the calcium phosphate precipita- 
tion method (Graham  and Van der Eb,  1973) followed by a  15% glycerol 
shock (Parker and Stark,  1979). SCC  13 cells were transfected by adding 
plasmid DNA in 150 ~tg/ml DEAE dextran (Pharmacia,  Inc.,  Piscataway, 
NJ) and 10 I~M chloroquine for 3 h followed by a 10% DMSO shock. Cells 
were fixed 65 h posttransfection unless otherwise  indicated in the text. 
Immunofluorescent Labeling 
For immunohistochemistry, cells were grown on glass chamber slides (Lab 
Tek, Miles Scientific Division,  Miles Laboratories,  Inc., Naperviile,  IL). 
After transfection, cells were washed with PBS, fixed in methanol (-20°C) 
for 10 rain, and washed in PBS. For actin labeling, cells were fixed in 3.7 % 
formalin for 10 rain at room temperature  and then rinsed with PBS. 
To detect K14-substance P-tagged proteins, we used the anti-P rat mono- 
clonal antibody NCl/34 (Cuello et al.,  1979). As a necessary prerequisite 
for NC1/34 antibody recognition, protein carboxyl groups were chemically 
converted to amides,  as described  by Munro and Pelham (1984). 
The mouse monoclonal antibodies LE-41 and LE-61 (Lane,  1982) were 
used to identify the endogenous PtK2 keratin network. Keratin Kl,~was de- 
tected using a polyclonal rabbit antibody isolated in this laboratory (Fuchs 
and Marchuk,  1983). Vimentin networks were identified using a rabbit poly- 
clonal antisera made against hamster vimentin (Hynes and Destree,  1978). 
Tubulin networks were stained using a rabbit polyclonal antibody (Gunder- 
sen et al., 1984), and actin was detected using rhodamine-conjugated phal- 
loidin (Molecular  Bioprobes,  Eugene,  OR). 
To visualize the primary antibody, we used the following fluorescently 
labeled secondary antibodies:  FITC-conjugated goat anti-rat IgG (Cappel 
Laboratories,  Inc.,  Cochranville,  PA; and Tago, Burlingame,  CA). Texas 
Red-conjugated goat anti-rabbit  IgG (Cappel Laboratories, Inc.), and Texas 
Red-conjugated  goat anti-mouse IgG (Tago). 
lmmunoblot Analysis 
Intermediate  filament proteins were isolated from transfected  PtK2 ceils 
using the procedure of Wu et al. (1982). Proteins were solubilized in 8 M 
urea and 10 % beta-mercaptoethanol, and separamd by SDS-PAGE. Proteins 
were electrophoretically  transferred to nitrocellulose paper (Towbin et al., 
1979). As with the immunolabeling of cells with the substance P antibody, 
it was necessary to chemically modify the protein bound to the nitrocellu- 
lose. After modification,  bound proteins were reacted with the substance 
P antibody, washed in PBS, and then reacted with rabbit anti-rat IgG (Miles- 
Yeda, Inc.,  Elkhart,  IN)  to increase the binding of ml-labeled Staphylo- 
coccus aureus protein  A. The radiolabeled  antibody-protein  complexes 
were visualized by autoradiography. 
Results 
Construction of  a Hybrid Kl4-Substance P cDNA 
Driven by the SV-40 Early Promoter and Enhancer 
Previously, clones containing 93 % of the human K14 cDNA 
(KB-2, Hanukoglu and Fuchs, 1982) and 100% of the human 
K14 gene sequence (GK-I, Marchuk et al., 1984; 1985) were 
isolated and sequenced. Since the coding sequence of the 
cDNA corresponded perfectly with the corresponding por- 
tion of the gene, we were able to construct a complete K14 
cDNA from the two clones. The details of the construction 
can be obtained in Materials and Methods.  The complete 
construct is shown in Fig.  1. 
There were two major considerations in designing our vec- 
tor for deletion mutation analyses: (a) We wanted to make 
certain that the sequences encoding the antigenic determi- 
nant of the protein were not lost during the construction of 
deletion mutants; (b) we wanted to be able to use immuno- 
fluorescence to  follow the  expression of our mutant  K14 
constructs even when they were transfected into K14-express- 
ing epidermal cells. To accomplish these goals we replaced 
the sequences encoding the last five amino acid residues of 
the human epidermal keratin K14 with a small (15 amino acid 
residue) neuropeptide sequence encoding the carboxy-ter- 
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sequence was retained in all of our deletion analyses (see be- 
low).  The hybrid K14-substance P  sequences were cloned 
into plasmid pJ1  (Land et al.,  1986),  immediately 3' to the 
SV-40 early promoter and enhancer sequence.  This hybrid 
plasmid will be referred to as pJK14-P. 
Transfection of  PtK2 Cells with pJKl4. P 
The kidney epithelial cell line PtK2, from kangaroo rat, was 
chosen for our initial transfection studies. These simple epi- 
thelial cells express only two keratins: the type I keratin K18 
and the type II keratin K8 (Lane, 1982).  Although K14 is not 
normally coexpressed with K8 in vivo, K8 can utilize K14 as 
a promiscuous partner for filament assembly in vitro (Hatz- 
feld and Franke,  1985).  In addition,  PtK2 cells transfected 
with the human epidermal keratin gene K14 can readily in- 
corporate K14 into the endogenous keratin filament network 
(Giudice and Fuchs,  1987). 
To make certain that the presence of the neuropeptide se- 
quence in K14-P did not interfere with the ability of the kera- 
tin to assemble into filaments, we transfected pJK14-P into 
PtK2 cells and examined the keratin network 65 h posttrans- 
fection.  A  monoclonal  antibody  against  substance  P  was 
Figure  2. K14.P readily incorporates into the endogenous keratin network of  transfected PtK2 cells. PtK2 cells were transfected with plasmid 
pJK14.P, and the fate of the transfected gene product was examined by double-label immunofluorescence. To visualize the transfected gene 
product, cells were stained with a rat monoclonal antibody (NC1/34; referred to as anti-P here) recognizing the carboxy-terminal sequence 
of substance P (a and c). Antibody staining was followed by fluorescein-conjugated goat anti-rat IgG. The endogenous simple epithelial 
keratin network was detected using a mouse monoclonal antibody (LFA1) to identify keratin K8, followed by Texas Red-conjugated  goat 
anti-mouse IgG (b). Both cells in this field were transfected, and thus, express the K14.P protein.  To demonstrate  that K14.P could be 
identified specifically with an antiserum specific for epidermal keratins, the double immunofluorescence was repeated, this time using an 
anti-type I epidermal keratin antiserum,  followed by Texas Red-conjugated  goat anti-rabbit IgG (at), and anti-P as described above (c). 
Bar, 20 t.tm. 
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quences coding for the carboxy-terminal end of 
K14. The stick diagram shows the location of the 
four helical domains (gray boxes; IA, IB, 2A, and 
2B) of the K14 keratin and (stippled box) the sub- 
stance P tag. (V) The sites of the deletions  used in 
our analyses.  Beneath the stick diagram is the se- 
quence of the carboxy-terminal region of K14.P. 
The fourth a-helical domain (2B) is boxed in gray; 
the substance P tag is identified by the bars above 
and below the sequence.  The exact points of the 
deletions  are identified  by arrows,  and the names 
of  the deletions are written above each arrow. Each 
deletion extends from the arrow to the solid trian- 
gle  immediately  preceding  the  substance  P  se- 
quence.  Construct nomenclature: C,  a  carboxy- 
terminal deletion; AX, the number of amino acid 
residues that are missing from K14.P as a result of 
the deletion. 
used to detect the presence of  K14.P by immunofluorescence. 
Monoclonal antibodies  against 1£8 (LFAI) and K18 (LE61) 
were used to identify the endogenous keratin filament net- 
work  (Lane,  1982).  Neither  LE41  or  LEbl  cross-reacted 
with K14. 
Fig. 2 a  shows that K14.P readily incorporated into the en- 
dogenous keratin filament network of  the PtK2 cell. Anti-KS 
(Fig.  2  b)  and  anti-K18  (not  shown)  showed  complete 
colocalization with anti-P, indicating that only a single heter- 
ogeneous keratin  filament  network comprised of all  three 
keratins existed in the transfected cells. Fig. 2, c and d demon- 
strate that K14-P could be identified specifically with either 
anti-P or with a polyclonal antiserum made against gel-puri- 
fied human KI4. Thus, by all criteria, the construct pJK14.P 
seemed to be suitable for our proposed mutagenesis experi- 
ments. 
Construction of  Mutant K14-Substance P cDNAs 
Plasmid pJK14.P has a unique Sal I site at the junction of the 
K14 and substance P  sequences.  It also has a unique Kpn I 
site within the coding portion of K14. These sites enabled us 
to generate deletion mutants in the K14 eDNA by: (a) linear- 
izing the plasmid pJK14-P with Sal I; (b) treating the linear- 
ized  plasmid  with  the  exonuclease  Bal  31  for  increasing 
intervals of time; (c) excising the series of K14 deletion frag- 
ments with the enzyme Kpn I; and (d) ligating the Kpn I-Bal 
31  deletion fragments to the large Kpn I-Sal I  fragment of 
plasmid pJK14- P. 
For  our  transfection  studies,  the  only  deletion  mutants 
used were those where the K14 and substance P  sequences 
were both in the same reading frame.  To determine the pre- 
cise location of each deletion, and to select those mutants in 
the correct reading frame, we prepared a DNA oligonucleo- 
tide just 3' from the substance P  sequence, and used this as 
a primer to determine the sequence at the K14-substance P 
junction  of each construct.  The deletion  constructs  which 
were chosen for study are shown in Fig. 3. These constructs 
will be referred to as CAX pJK14.P, where X represents the 
Figure 4. Immunoblot analysis of the mutant keratins  expressed  in 
CAX pJK14.P transfected  PtK2 cells.  Intermediate filaments were 
isolated from CAX pJK14.P transfected  PtK2 cells. Filaments  were 
dissociated  in 8 M urea and 10% 13-mercaptoethanol, and the pro- 
teins were resolved by SDS-PAGE. Proteins were transferred  elec- 
trophoretically to nitrocellulose  paper,  and the paper was exposed 
to anti-P antibodies,  followed by ~:5I-labeled S.  aureus protein A 
(Towbin et al., 1979). Radiolabeled bands containing antibody-pro- 
tein  complexes were  visualized  by autoradiography.  IF extracts 
were isolated from cells transfected  with: lane 1, no DNA; lane 2, 
pJK14.P;  lane 3, CAll pJK14.P;  lane 4, CA42 pJK14.P;  lane 5, 
CA50 pJK14.P; lane 6, CA73 pJK14-P; lane 7, CA135 pJK14.P. The 
sample in lane 8 is a keratin extract from cultured human epidermal 
cells. The arrow at the left identifies the migration of the epidermal 
keratin KI4 (as judged by staining with Coomassie Blue).  None of 
the epidermal keratins showed cross-reactivity with anti-P. Molecu- 
lar mass markers are shown in kilodaltons  at the left. 
Albers and Fuchs Transfection of Mutant Keratin cDNAs  795 Figure 5. The removal of the nonhelical carboxy terminus  of K14 does not interfere  with its ability  to incorporate into the PtK2 keratin 
network. PtK2 cells were transfected  with CAll pJK14.P (a and b) or CA42 pJK14.P (c and d). The transfected  cells were identified  by 
immunofluorescence using anti-P, followed by fluorescein-conjugated  goat anti-rat IgG (a and c). The endogenous keratin  network was 
visualized  by staining  with LE41, followed by Texas Red-conjugated goat anti-mouse IgG (b and d).  Bar,  20 lam. 
number of amino acid residues  removed from the carboxy 
terminus of the encoded K14 as a consequence of  the deletion 
in the eDNA. 
Mutant Keratin Proteins Are Expressed when Deletion 
Constructs of  pJK14. PAre Transfected into PtK2 Cells 
Deletion constructs of pJK14-P ranging from CAll to CA135 
were transfected into PtK2 cells, and keratins were extracled 
65 h  posttransfection.  When the isolated keratins  were re- 
solved by SDS-PAGE and subjected to immunoblot analyses 
using an antibody specific for substance P  (Fig. 4), a single 
major  discrete  protein  band  was  detected  in  each  extract 
from transfected PtK2 cells.  The K14.P band (Fig.  4,  lane 
2) migrated at slightly slower electrophoretic mobility than 
Figure 6. The removal of 10 amino acid residues  at the carboxy end of the fourth a-helical domain causes a marked defect in the ability 
of K14-P to incorporate into the PtK2 keratin network.  PtK2 cells were transfected with CA50 pJK14-P and examined 65 h posttransfection. 
The mutant keratin was detected by staining with anti-P, followed by fluorescein-conjugated  goat anti-rat IgG (a, c, and e). The endogenous 
keratin  network of each frame was visualized  by staining with LE41, followed by Texas Red-conjugated goat anti-mouse IgG (b, d, and 
f). At early times (14-30 h) after transfection,  most cells showed a morphology similar to that seen in a and b. By 65 h when the expression 
of the transfected  keratin seemed to be optimal, ,x,85% of the transfected  cells showed a collapsed coil network (c-f). In transfected  cells 
showing either of these distinct  keratin networks,  spheroid bodies containing  mutant and endogenous keratins  could often be seen (c-f). 
Bar,  20 ~tm. 
The Journal of Cell Biology, Volume 105, 1987  796 Albers and Fuchs Transfection  of Mutant Keratin cDNAs  797 Figure 7. Deletions that progressively lack greater mounts of the a-helical domain of KI4.P show more severe perturbations of the endoge- 
nous keratin network.  PtK2 ceils were transfected with either CA73 pJKI4.P (a and b) or CA135 pJK14-P (c-f) and examined by im- 
munofluorescence.  Cells were stained with both anti-P (a, c, and e) and LE41 (b, d, and f) as described in the legend to Fig. 2. (a-d) 
Cells examined at 65 h posttransfection;  (e and f) cells examined at 92 h posttransfection.  Note that LE41 and anti-K8 staining do not 
colocalize in the 92-h cells (e and f). Bar, 20 ttm. 
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man K14 which did not cross react with anti-P). For each 
progressively larger deletion in K14.P, the detected protein 
migrated with increasing electrophoretie mobility (Fig. 4, 
lanes 3-7). For all deletion constructs, the transfected eDNA 
product appeared to be stable, and its size was comparable 
to that predicted on the basis of sequence analysis. 
The bands detected by immunoblot analyses were not de- 
tectable by silver staining. This was expected since all of 
our experiments involved transient transfections, and 95 % of 
the IF extract represented protein from untransfected cells. 
Moreover, because the number of plasmid DNAs taken up 
by each transfected cell was variable, it was impossible to de- 
termine the ratio of mutant to endogenous keratin in the 
transfected cells. 
Kl4. P Mutants Missing Various  Portions of  the 
Nonhelical Carboxy-terminal  Domain Incorporate 
Readily into the Keratin Network of  PtK2 Cells 
To determine whether the removal of a portion of the nonhel- 
ical carboxy-terminal domain of KI4.P can interfere with its 
ability to integrate into a keratin filament network, we trans- 
fected PtK2 cells with CAll pJK14.P. Fig. 5, a and b shows 
clearly that this mutant, missing II additional amino acid 
residues of K14, incorporated into the PtK2 keratin network 
without disturbing its morphology. Bundles of keratin fila- 
ments containing KS, K18, and CAll K14.P extended through- 
out the cytoplasm of each transfected PtK2 cell. Since single 
keratin filaments were not visualized in these frames, we 
could not determine whether the incorporation of subunits 
was restricted to newly synthesized filaments. 
When PtK2 cells were transfected with CA42 pJK14.P, the 
expressed mutant hybrid protein again colocalized with the 
endogenous keratin network (Fig. 5, c and d). The mutant 
K14.P, this time missing 42 additional amino acid residues 
of K14, incorporated into the PtK2 keratin network without 
any apparent alterations in morphology. This was striking, 
because this mutant left just two K14 amino acid residues 
(plus 15 amino acids from the neuropeptide sequence) after 
the highly conserved sequence T Y R R L L E G E at the 
end of the fourth helical domain.  Thus,  even though the 
entire nonhelieal carboxy-terminal domain of K14 was miss- 
ing in this construct, it still seemed competent to assemble 
into keratin filaments. 
Mutant Kl4. P Keratins Missing Portions of  the Fourth 
Helical Domain Eh'srupt the Keratin Filament Network 
of  PtK2 Cells 
In contrast to the behavior of mutants lacking portions of the 
K14 nonhelical carboxy-terminal domain, mutants missing 
portions of the or-helical segment caused a marked disrup- 
tion in the keratin filament network of the PtK2 cells. This 
could be seen even with a mutant CA50 pJK14.P, missing 
only the R L L E G E  residues at the extreme end of the 
fourth helical domain (Fig. 6).  In 85%  of the transfected 
cells,  the mutant keratins incorporated into PtK2  keratin 
filaments, but in so doing they caused a collapse of the en- 
tire keratin filament network. At early times (t =  18-30 h) 
after transfection, the keratin network appeared as a single 
straightened cable of collapsed filaments (Fig. 6 a).  Small 
branches of filaments could often be seen protruding from 
this macrofibrillar structure. Regardless of the architecture 
observed, LE41  staining always showed complete colocal- 
ization of the endogenous and mutant keratins (Fig. 6 b). 
At 65-h posttransfection, when the expression of mutant 
keratin seemed to be optimal, the cables of filaments were 
frequently seen coiled in a  clump near the nuclear enve- 
lope (Fig. 6,  c-f). Most transfected cells also exhibited a 
few keratin-containing spheroid bodies in their cytoplasm. 
Whereas at earlier time points many cells were seen with a 
straightened cable network (Fig. 6, a and b), now only a few 
of these cells could be found (not shown). Very rarely, CA50 
pJK14.P transfected cells produce a hybrid keratin network 
that was indistinguishable from that of  an untransfected PtK2 
cell (lower cell in Fig. 6, c and d). Collectively, our findings 
suggest that the collapsed coil structures may require a high- 
er level of mutant protein than the cables, and that the two 
different  abnormal structures may share a precursor-product 
relation. 
Interestingly, at later times (92 h) after transfection, few 
if any cells had collapsed coils of filaments while many cells 
had a keratin network which appeared to be almost normal 
(not shown). At these late times, some cells showed evidence 
of the filament cables seen very early after transfection, but 
in these cases the network was more extended and not as 
thick. These observations raise the possibility that the syn- 
thesis of mutant protein may be declining between 65 and 
92 h posttransfection. 
When PtK2 cells were transfected with CA73 pJKI4.P, the 
resulting network of  keratins was dramatically different from 
that seen in CA50 pJK14.P transfected cells (Fig. 7). While 
both anti-P  (Fig.  7  a) and LE41  (b)  antibodies stained a 
single network of fibrous structures in the cytoplasm of most 
transfected cells, the network of filaments was dearly abnor- 
mal. At early times after transfection, most cells showed a 
morphology similar to the right cell in Fig. 7, a and b. Fila- 
ment bundles were generally thin and the filaments them- 
selves were often short and discontinuous. Branchlike struc- 
tures were also observed, giving the filaments a bent or kinked 
appearance. At 30-65 h posttransfection, cells with cytoplas- 
mic spheroid bodies of keratin could also be seen (e.g., 
transfected cell shown at left in Fig. 7, a and b). In these cells 
keratin did not seem to be involved in filamentous structures. 
The kinetics of appearance of the nonfilamentous aggregates 
suggest that they arise when the discontinuous filaments in- 
corporate a critical level of mutant protein. Larger deletions 
into the fourth helical domain had an even more profound 
effect on the ability of  mutant keratin to disrupt the PtK2 ker- 
atin network. The largest deletion that we examined was 
CA135 pJK14.P, encoding a mutant keratin missing almost 
its entire fourth helical domain. When expressed in trans- 
fected PtK2 cells, this mutant accumulated as protein aggre- 
gates (Fig. 7 c). The mutant clearly retained its ability to in- 
teract with the PtK2 keratins, however,  as indicated by the 
colocalization of LE41  in these aggregates (Fig. 7 d). 
The spheroid bodies in CA135 pJK14.P-transfected cells 
were similar in appearance to those seen when antikeratin 
antibodies were microinjected into simple epithelial cells 
(Klymkowsky et al., 1983; Tolle et al., 1985). In contrast to 
the antibody microinjection experiments,  our transfection 
experiments would not a priori be expected to disturb the 
preexisting keratin network. Nonetheless, even though a net- 
work of normal keratin filaments must have existed at the 
time mutant keratin was first expressed, no filamentous struc- 
tures containing keratin were found in any of the transfected 
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graded and resynthesized at an extremely rapid rate, the mu- 
tant must have not only interfered with the formation of new 
keratin  filaments,  but  also  disrupted  the  existing  keratin 
cytoskeleton. 
While the size of the aggregates was smaller, the morphol- 
ogy seen in Fig.  7,  c and d  was observed in some CA135 
pJK14.P-expressing cells at times as early as 18 h posttrans- 
fection. Thus, even low levels of this mutant keratin seemed 
to cause chaos within the endogenous PtK2 network of kera- 
tins. Moreover, cell division did not appear to be a necessary 
prerequisite for the formation of this dramatically altered 
cytoskeleton, since a number of lone transfected cells could 
be seen bearing this abnormal morphology. 
When CA135 pJK14-P-transfected cells were examined at 
92 h posttransfection, anti-P still stained spheroid bodies in 
the cytoplasm (Fig. 7 e), while LE41 staining was marked- 
ly reduced in these aggregates (f). These results were simi- 
lar,  but  more  striking  than  the  results  obtained with  the 
CA50 mutant. Even more surprising was the appearance of 
seemingly normal keratin filament networks surrounding the 
nuclei of  the transfected cells. Interestingly, some transfected 
ceils  were binucleate,  and occasionally in these cells the 
filamentous network seemed to surround only one of the 
nuclei (see Fig. 7, e and  f). In all cases these filamentous net- 
works  stained  with  LE41  but  not  with  anti-P,  indicating 
that the  mutant keratin was  largely if not completely ex- 
cluded from these filaments. The simplest explanation for 
this phenomenon is that the expression of the mutant keratin 
decreased dramatically between 65 and 92 h posttransfection 
while endogenous keratin synthesis continued,  showing a 
perinuclear initiation of newly formed 8-urn filaments. Fail- 
ure of the existing mutant keratin to assemble into the newly 
synthesized keratin filaments suggests that once incorporated 
into aggregates, the mutant keratins are at least partially in- 
hibited from freely exchanging with the subunits in the fila- 
ments. In contrast, the reduction in LE14 fluorescence in the 
aggregates could mean that K8 and K18 more readily ex- 
change with the newly forming filament network. 
Examining the Effects of  Mutant-induced 
Perturbations of the Keratin Network on Other 
Cytoskeletal Architectures 
We wondered whether the mutant-induced disruptions of the 
endogenous keratin networks might also perturb some of the 
other cytoskeletal components of the transfected PtK2 cells. 
To investigate this possibility, we transfected PtK2 cells with 
CA135 pJK14.P,  and examined the endogenous networks of 
vimentin filaments, microtubules, and actin microfilaments 
by immunofluorescence (Fig.  8).  Our results show clearly 
that the mutant keratin network did not affect the filamentous 
networks containing vimentin (Fig.  8, a  and b), tubulin (c 
and d), or actin (e and f). Similar results were obtained for 
cells transfected with the  other mutant keratin constructs 
(data not shown). These observations are in agreement with 
previous studies using microinjection of antikeratin antibod- 
ies (Klymkowsky et al.,  1983).  The data indicate that even 
when grossly permuted, the keratin filament network of a cell 
does not seem to influence the structural integrity of  the other 
cytoskeletal components. 
Expression of  Mutant KI4.P Proteins in Squamous Cell 
Carcinoma Cells of the Skin 
Since both type I and type II keratins seem to be essential 
for filament assembly (Hatzfeld and Franke, 1985; Eichner 
et al.,  1986), the foreign expression of K14.P and its mutant 
derivatives in PtK2 cells must have forced them to choose the 
type II keratin K8 as a promiscuous partner in filament for- 
mation. Although studies have shown that K14 and K8 as- 
semble into bona fide 8-nm filaments in vitro (Hatzfeld and 
Franke, 1985), it was important to determine whether the be- 
havior of K14.P and its derivatives is similar in cells where 
K5, the true partner of K14 (Nelson and Sun, 1983), is pres- 
ent. For this investigation, we transfected pJK14-P and its de- 
rivatives into SCC-13 cells, a line derived from a squamous 
cell carcinoma of human skin (Wu and Rheinwald,  1981). 
These cells express seven different keratins:  K5, K6,  K13, 
K14, K16, K17, and K19. The overall level of keratins in these 
ceils is approximately five times higher than in PtK2 cells. 
The behavior of pJK14-P, CAll pJK14.P, and CA42 pJK14.P 
in SCC-13 cells was similar to that observed in the transfected 
PtK2 cells. In all three cases, the transfected gene product 
incorporated  into  the  preexisting  keratin  network  of the 
SCC-13  cells without causing  any apparent perturbations. 
Fig. 9, a and b shows one example of this, namely a pJK14.P- 
transfected SCC-13  cell. 
Unexpectedly, transfection of CA50,  CA73,  and CA135 
pJK14.P into SCC-13  cells also yielded hybrid keratin net- 
works that were almost always indistinguishable from those 
of untransfected cells (data not shown).  At all times post- 
transfection, only a small percentage of transfected SCC-13 
cells showed abnormal structures resembling those observed 
for the transfected PtK2 cells (see Fig. 9, c-e for rare exam- 
ples;  CA135  pJK14.P).  Even these  fe£v clearly abnormal 
cells still retained remnants of a  normal filamentous net- 
work. These results suggest that either: (a) the ratio of mu- 
tant to endogenous kemtins is too low to elicit the abnormal 
filament morphology in the SCC-13 cells, or alternatively (b) 
the structure of the keratin network in SCC-13 cells is more 
stable than it is in PtK2 cells. 
Knapp et al. (1983) have observed a reorganization of  kera- 
tin filaments upon treatment of cultured fetal mouse epider- 
mal cells with a mixture of cytochalasin B (to disrupt actin 
microfilaments) and colchicine (to disrupt microtubules). A 
recent study by Kitajima et al.  (1986)  indicated that cyto- 
chalasin B alone is sufficient to induce this perturbation in 
the keratin networks of human epidermal ceils. A priori, the 
disruption of the microfilament network could induce a per- 
Figure 8. Other cytoskeletal architectures of the PtK2 cell are not perturbed even when the keratin filament network is collapsed. PtK2 
cells were transfected with CA135 pJK14.P and examined by immunofluoreseence at 65 h posttransfection. Cells were stained with anti-P 
(a, c, and e) as described in the legend to Fig. 2. Cells in a were eostained with a rabbit antiserum made against hamster vimentin, followed 
by Texas Red--conjugated  goat anti-rabbit IgG (b). Cells in c were costained with a rabbit antiserum made against porcine tyrosinated tubu- 
lin, followed by Texas Red-conjugated goat anti-rabbit IgG (d). Cells in e were costained with rhodamine-conjugated phalloidin (f). Bar, 
20 ~tm. 
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with CA135 pJK14.P and fixed at 80 h posttransfection.  Cells in a were stained with anti-P as described in the legend to Fig. 2. The actin 
network of these cells (b) was detected by costaining with rhodamine-conjugated  phalloidin.  Bar, 20 grn. 
turbation in the keratin filament network either because the 
two networks are physically linked, or because the microfila- 
ment network provides an architectural  support necessary 
for the stability of the keratin network.  To distinguish be- 
tween these two possibilities, we disrupted the keratin fila- 
ment network by transfection with CA135 pJK14.P, and ex- 
amined the  actin  microfilament network of SCC-13  cells. 
Complete disruption of the keratin filaments did not induce 
any  detectable change  in the  microfilament network (Fig. 
10). The microtubule network showed no aberrations either 
as a consequence of mutant-induced disruption of the keratin 
filament network (data not shown). Thus, it seems unlikely 
that either the microfilament or the microtubule networks are 
covalently interconnected  with the keratin filaments in the 
cultured keratinocyte. 
Discussion 
In this paper, we began to examine contributions that differ- 
ent portions of a keratin sequence make in defining the over- 
all  keratin  filament network within  a  cell.  Tagging a  K14 
cDNA with a small neuropeptide sequence was a prerequi- 
site to tracing the expression of K14 and its mutant derivatives 
both in  simple epithelial cells,  where the gene is not nor- 
mally expressed, and in epidermal cells, where the expres- 
sion of K14 accounts for ,,o7  % of the total protein of the cell. 
Although  we cannot unequivocally rule out the possibility 
that the replacement of the last five amino acid residues of 
the K14 chain with a  D-residue peptide might have caused 
slight perturbations in the overall keratin filament networks 
of the transfected cells, no difference could be detected by the 
immunofluorescence techniques that we used. 
Our rationale behind tagging the carboxy-terminal end of 
K14 stemmed from three independent studies. In one study, 
Steinert and co-workers (1983) demonstrated that mild chy- 
motryptic proteolysis of intact mouse epidermal keratin illa- 
ments, resulting in the apparent removal of more than half 
of the  nonhelical ends of the keratins,  did not disrupt the 
8-nm  structure.  In another  study,  Kaufmann et al.  (1985) 
showed that removal of  almost half of the nonhelical carboxy- 
terminal residues of desmin produced a protein that was still 
able to assemble into  10-nm filaments. In contrast,  the re- 
moval of 67 amino acid residues at the amino-terminal end 
rendered desmin incompetent for filament assembly on its 
own. Finally, the recent report of the sequence for the small- 
est known keratin K19 has revealed that this protein has a 
13-amino acid extension of the a-helical rod and no nonheli- 
cal tail, and yet it appears to be fully competent in filament 
assembly (Bader et al.,  1986).  Collectively, these data indi- 
cated  that  the  "safest" place to  perturb  the  K14  sequence 
might be at the extreme carboxy-terminal end of the chain. 
The results of our transfection studies with the mutant ker- 
atin  CA42  K14.P confirmed and extended earlier findings 
Concerning the role of the nonhelical carboxy-terminal end 
of IF proteins in filament formation. In fact, this entire do- 
main could be removed without perturbing the ability of K14 
to incorporate into keratin filaments. Whether the transfected 
cells were of simple epithelial  or of epidermal origin did 
not  seem to make a  difference,  indicating  that the  K14.P 
could readily accept a promiscuous partner in filament for- 
Figure 9.  The response of squamous cell carcinoma cells (SCC-13) to transfection with CA135 pJK14-P is distinctly  different from that 
of PtK2 cells. SCC-13 cells were transfected with pJK14.P (a and b) and CA135 pJK14.P (c-e) and examined at various times after transfec- 
tion by immunofluorescence. The transfected cells shown in a-d were fixed at 26 h posttransfection. The cell in e was fixed at 53 h posttrans- 
fection. The transfected gene products were detected by staining with anti-P (a, c, and e) as described in the legend to Fig. 2. The endogenous 
keratin network was visualized by staining with a rabbit antiserum made against type II epidermal keratins, followed by Texas Red-con- 
jugated goat anti-rabbit IgG (b and d). The cell overlapping the transfected cell shown in c and d is suprabasal: it appeared as a consequence 
of stratification in the SCC43 cultures.  Bar, 20 gm. 
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of K14 with  a  foreign peptide  sequence did not  seem to 
influence the competence of K14 for filament formation, nor 
did it alter the gross morphology of the resulting filament 
network. Thus, unless a carboxy-terminal sequence gener- 
ates a tertiary structure that in some way blocks the ability 
of keratin subunits to pack into the 8-urn filament, its se- 
quence per  se  may be largely irrelevant in  the assembly 
process. 
In the experiments that we conducted, normal type I kera- 
tins were always present in the transfected cells expressing 
our mutant type I keratin construct. We do not yet know how 
the mutant keratins would perform in filament assembly un- 
der conditions where other type I keratins are absent. How- 
ever, we predict that at least some of our mutants, particu- 
larly those that have lost helical residues, will not be able to 
assemble into normal 8-nm filaments when they are the sole 
type I  keratin used in filament formation.  This is already 
forecast from our kinetics studies where the accumulation of 
a critical level of certain mutants appeared to trigger a col- 
lapse of the endogenous keratin filament network. To inves- 
tigate this issue in more detail, permanent mammalian cell 
lines or keratin-expressing bacterial lines must be cloned to 
produce sufficient quantities of mutant proteins for in vitro 
assembly studies. 
while certain questions about filament assembly neces- 
sitate  in  vitro  assembly  studies  involving  mutant  keratin 
polypeptides, other important aspects of filament formation, 
filament  stability,  and  intracellular  interactions  involving 
keratin filaments can only be addressed using a transfection 
approach. Indeed, one of our most significant findings was 
the realization that even low levels of a single mutant keratin 
can be sufficient to cause the collapse of the entire endoge- 
nous keratin network. This was particularly evident when 
PtK2 cells were transfected with the mutant CA135 pJK14.P: 
within just 18 h transfected cells produced sufficient amounts 
of mutant protein to disrupt the keratin filament network. 
A priori, there are two major reasons why both the preex- 
isting keratin filament network and the newly synthesized 
keratin  filaments  should  collapse  simultaneously:  (a)  If 
newly  synthesized  keratins  do  not  freely exchange  with 
preexisting filaments, then the cytoskeleton of transfected 
cells would consist of  a heterogeneous mixture of  normal and 
abnormal keratin filaments. In this case, abnormal filaments 
would have to cause a perturbation in the normal keratin fila- 
ment network, presumably via interfilament interactions. (b) 
If a dynamic equilibrium exists such that keratin subunits are 
continuously exchanged along the filament core of new and 
old filaments alike, then all keratin filaments of transfected 
cells would contain mutant keratins. If the rate of exchange 
is significantly high, 100% of the keratin filaments would be 
destabilized. 
while it is plausible that a heterogeneous mixture of nor- 
mal and mutant filaments might cause a lateral aggregation 
of filaments  similar to that seen in  CA50 pJK14.P-trans- 
fected cells, it seems unlikely that interactions between nor- 
mal and mutant filaments could reduce both structures to the 
partially  polymerized aggregates  of keratin  subunits  ob- 
served for CA135  pJK14-P-transfected cells.  On the other 
hand, if mutant subunits integrate into both preexisting and 
newly synthesized filaments, it seems remarkable that the 
level of exchange between keratin subunits could be so great 
as to cause the disintegration of the keratin filament network. 
Although no indication of a constant dynamic equilibrium 
has thus far been substantiated for the keratin subunits and 
filaments, there have been reports of cell cycle-dependent 
changes in filament organization. In a number of simple epi- 
thelial cell lines, radical shape changes accompanied by a re- 
organization  of keratins  occur transiently  during  mitosis 
(Horwitz et al., 1981). Initially, filament bundles are severed 
into shorter tufts of fibrils (Aubin et al., 1980). Subsequent- 
ly, individual keratin filaments are partially unraveled into 
protofibrillar threads and finally into knotlike dense gran- 
ules, or spheroidal cytoplasmic bodies (Franke et al., 1982). 
While globular keratin-containing aggregates have not been 
seen in mitotic PtK2 cells (Franke et al.,  1978; Aubin et al., 
1980; Horwitz et al.,  1981), some severing of keratin fibrils 
may take place (Aubin et al.,  1980; Franke et al.,  1982).  It 
has been suggested that since the bundles of keratin fibrils 
in PtK2 cells are unusually thick, they may not dissociate as 
completely as in other mitotic cells (Franke et al.,  1982). 
Our data indicate that the keratin filament network may be 
in a  dynamic state of flux throughout the cell cycle, even 
when no gross changes in filament organization can be seen. 
This might also be true for SCC-13  cells, although it was 
more difficult to discern because many fewer mutant-trans- 
fected SCC-13  cells  showed  a  collapsed  keratin  filament 
network. 
We were surprised to discover that the "recovery process" 
of cells transfected with our keratin mutants was not simply 
the reverse of the initial events following transfection. This 
was especially true for the CA135 pJK14-transfected cells, 
where at early times after transfection, newly synthesized 
mutant keratin incorporated into and caused the disruption 
of preexisting keratin filaments, whereas at late times after 
transfection no mutant keratin was incorporated into newly 
synthesized keratin filaments. 
In most transient transfections, the expression of the trans- 
fected gene product begins to wane after about 65 h (for re- 
view see Gorman, 1985). Therefore, it is likely that most of 
the mutant keratin seen at 92 h posttransfection is due to pro- 
tein synthesized at earlier times.  This must mean that al- 
though newly synthesized mutant keratin can incorporate 
into a preexisting PtK2 network, it is partially if not fully re- 
stricted once it enters the spheroid bodies. Oddly, while the 
level of  mutant keratin in the spheroid bodies remained high, 
LE41 staining of the spheroid bodies was reduced by 92 h 
posttransfection.  Whether K8  and K18 might be  released 
from the spheroid bodies more effectively than the mutant 
keratin remains to be determined. 
Irrespective of the molecular mechanisms underlying the 
process, the complexing of endogenous keratins into sphe- 
roid bodies enabled us to examine what happens when the 
existing  keratin  network is  removed from  a  cell,  and  is 
recreated largely de novo. Interestingly, newly synthesized 
keratin filaments formed almost exclusively around the nu- 
cleus. This result provides in vivo evidence in support of  ear- 
lier studies by Eckert et al. (1982), who showed that purified 
keratin, solubilized in 8 M urea and added to Triton X-100- 
extracted PtK1 cells, associated preferentially with the nuclei 
of extracted cells  when  filament  assembly  was  induced. 
whether keratin filament assembly is actually initiated on 
the nuclear envelope is still uncertain. 
In summary, a number of discoveries have been made as 
a consequence of expressing mutant epidermal keratins in 
epidermal  and  simple  epithelial  cells.  Most  importantly, 
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equilibrium between keratin subunits and the filament net- 
work within the cell.  Our findings are particularly relevant 
to the question of whether a single mutant keratin might be 
sufficient to cause havoc on a keratin filament network in a 
cell already expressing a number of normal type I and type 
II keratins. Our results indicate that neither epidermal nor 
simple epithelial cells have a mechanism that excludes newly 
synthesized  mutant keratins  from their  filament network. 
While the effects of the mutants seem to be less severe for 
epidermal cells than for simple epithelial cells,  the appear- 
ance of a few transfected cells with grossly abnormal pheno- 
types suggests that the stability of the epidermal network in 
mutant-expressing cells may be weakened even if it does not 
always collapse.  Thus, unless a cell develops a mechanism 
for shutting offthe expresson of a mutant keratin gene, a ma- 
jor component of its cytoskeletal architecture seems to be 
destined for perturbation or disruption. Although no human 
skin diseases have yet to be attributed to a mutation in a kera- 
tin gene, our results suggest that a single keratin gene muta- 
tion could be a possible candidate for an alteration in the ker- 
atin filament network. Further studies will be necessary to 
determine whether epidermal cells retain their viability and 
proper growth rates after transfection with our mutants. 
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